GLASSIA

搜索文档
Kamada Confirms Continuous Global Business Operations and Products Availability Despite Recent Events in the Middle East
Globenewswire· 2025-06-17 19:00
"While events in the Middle East are evolving, the operations and ongoing manufacturing of our products continue as planned," said Amir London, Kamada's Chief Executive Officer. "Although our shipments from Israel may be temporarily affected by the current closing of the Israeli airspace, our distribution centers outside Israel, as well as our partners and distributors worldwide, have sufficient level of products available, and we do not foresee shortage in meeting client demands. We are focused on our busi ...
Kamada .(KMDA) - 2025 Q1 - Earnings Call Transcript
2025-05-14 21:32
Kamada (KMDA) Q1 2025 Earnings Call May 14, 2025 08:30 AM ET Company Participants Brian Ritchie - Managing DirectorAmir London - Chief Executive OfficerChaime Orlev - Chief Financial OfficerAnnabel Samimy - Managing Director Conference Call Participants Jim Sidoti - Analyst Operator Greetings, and welcome to the Comida First Quarter twenty twenty five Earnings Conference Call. At this time, all participants are in a listen only mode. A question and answer session will follow the formal presentation. As a re ...
Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025
Globenewswire· 2025-05-07 19:00
文章核心观点 卡玛达公司将于2025年5月14日美国金融市场开盘前公布2025年第一季度财务结果,并于当天上午8:30举行投资社区电话会议讨论结果并答疑 [1][2] 财务结果公布与会议安排 - 公司将于2025年5月14日美国金融市场开盘前公布2025年第一季度财务结果 [1] - 公司管理层将于5月14日上午8:30举行投资社区电话会议讨论结果并答疑,股东和感兴趣方可通过特定号码参与,会议将在指定网址网络直播 [2] 公司概况 - 卡玛达公司是一家商业阶段的全球生物制药公司,专注于罕见和严重疾病产品,是专业血浆衍生疗法领域的领导者 [1][3] - 公司控股股东为以色列领先私募股权公司FIMI Opportunity Funds,持有约38%的流通普通股 [3] 公司战略 - 公司通过四个主要增长支柱实现盈利增长:一是商业活动的有机增长,包括对自有产品商业化和生命周期管理的持续投资,以及在以色列推出生物仿制药;二是获取新的业务发展、授权、合作和并购机会,以增强产品组合;三是扩大血浆采集业务,支持收入增长;四是利用制造、研发专业知识推进新产品候选药物的开发和商业化,主要产品候选药物为吸入性AAT [3] 联系方式 - 首席财务官Chaime Orlev,邮箱IR@kamada.com [4] - LifeSci Advisors, LLC的Brian Ritchie,电话212 - 915 - 2578,邮箱britchie@LifeSciAdvisors.com [4]
Kamada .(KMDA) - 2024 Q4 - Earnings Call Transcript
2025-03-06 00:06
Kamada Ltd. (NASDAQ:KMDA) Q4 2024 Earnings Conference Call March 5, 2025 8:00 AM ET Company Participants Brian Ritchie – LifeSci Advisors Amir London – Chief Executive Officer Chaime Orlev – Chief Financial Officer Conference Call Participants Annabel Samimy – Stifel Anthony Petrone – Mizuho Group James Sidoti – Sidoti & Co. Operator Greetings, and welcome to the Kamada Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time all participants are in a listen-only mode. A brief question-and-a ...